| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:64902257:3388 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:64902257:3388?format=raw |
LEADER: 03388mam a2200361 a 4500
001 4054776
005 20221027025210.0
008 970611t19971997enka b 001 0 eng d
010 $a 96086288
020 $a0412638207
035 $a(OCoLC)ocm37049393
035 $9AMK1879HS
035 $a(NNC)4054776
035 $a4054776
040 $aUUE$cUUE$dNNC-M$dOrLoB-B
245 00 $aHemophilia /$cedited by C.D. Forbes, L.M. Aledort and R. Madlock.
250 $a1st ed.
260 $aLondon :$bChapman & Hall,$c[1997], ©1997.
300 $aix, 380 pages, color plates :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes index and bibliographic references.
505 00 $g1.$tThe early history of hemophilia /$rC. D. Forbes --$g2.$tHemostatic mechanisms: why hemophiliacs bleed /$rO. D. Ratnoff --$g3.$tThe molecular defect in hemophilia A /$rG. Kemball-Cook and E. G. D. Tuddenham --$g4.$tThe molecular biology of hemophilia B /$rH. R. Roberts and D. K. Liles --$g5.$tThe diagnosis of hemophilia A and B and von Willebrand's disease /$rK. A. Rickard --$g6.$tDiagnosis of hemophilia A and B carriers and prenatal diagnosis /$rA. C. Goodeve and I. R. Peake --$g7.$tGenetic counseling in hemophilia /$rD. E. Wilcox and J. M. Connor --$g8.$tCentral and peripheral nervous system bleeding /$rJ. P. Hanley and C. A. Ludlam --$g9.$tOral bleeding /$rS. Sindet-Pedersen --$g10.$tMusculoskeletal bleeding in hemophilia /$rR. Madhok --$g11.$tPseudotumors (hemophilic blood cysts) /$rM. S. Gilbert --$g12.$tHemophilia and sport /$rP. M. Jones and B. M. Buzzard --$g13.$tVisceral bleeding /$rM. J. Inwood --$g14.$tThe treatment of hemophilia: comprehensive hemophilia care /$rL. M. Aledort --
505 80 $g15.$tPrinciples of management of hemophiliac bleeding /$rS. V. Seremetis --$g16.$tHome therapy /$rM. W. Hilgartner, D. Cardi and I. Goldberg --$g17.$tFactor VIII concentrates /$rE. Berntorp --$g18.$tDesmopressin (DDAVP) /$rS. Lethagen --$g19.$tFactor IX concentrates /$rJ. M. Lusher --$g20.$tInhibitors in hemophilia /$rL. W. Hoyer --$g21.$tBleeding in the hemophilia carrier /$rI. A. Greer and I. D. Walker --$g22.$tManagement of hemophilia during surgery /$rN. L. Kobrinsky and D. A. Stegman --$g23.$tinfectious complications of blood products /$rB. L. Evatt and W. C. Hooper --$g24.$tLiver disease in hemophilia /$rM. E. Eyster --$g25.$tHIV-1 infection in hemophilia /$rJ. J. Goedert and B. L. Kroner --$g26.$tNon-infectious complications of hemophilia /$rC. R. M. Hay and P. H. B. Bolton-Maggs --$g27.$tSafer clotting factor concentrates /$rP. R. Foster, B. Cuthbertson and R. V. McIntosh [et al.] --$g28.$tThe family and hemophilia /$rI. Markova --$g29.$tThe cost of hemophilia care /$rR. A. Lipton --
505 80 $g30.$tPsychosocial services in hemophilia /$rL. J. Haas, J. R. Schultz and M. A. Rigdon --$g31.$tLife assurance in hemophilia /$rP. Wilkie.
650 2 $aHemophilia A$xhistory.$0https://id.nlm.nih.gov/mesh/D006467Q000266
650 2 $aHemophilia A$xepidemiology.$0https://id.nlm.nih.gov/mesh/D006467Q000453
650 2 $aHemophilia A$xdiagnosis.$0https://id.nlm.nih.gov/mesh/D006467Q000175
650 2 $aHemophilia A$xtherapy.$0https://id.nlm.nih.gov/mesh/D006467Q000628
700 1 $aForbes, C. D.
700 1 $aAledort, L. M.
700 1 $aMadlock, R.
852 00 $boff,hsl$hRC642$i.H45 1997 Q